For Patients:

For patients interested in participating in a clinical study, please contact a clinical study site that is currently accepting patients for your type of cancer. Note that not all patients will qualify for the study requirements and enrollment is very limited. AuroLase® Therapy is an investigational medical device and is only available through designated clinical study sites.

BACK TO TOP

For Clinicians:

A brief summary of the enrollment criteria for current clinical studies is available. For more information regarding basic research, clinical studies, or other topics regarding AuroLase® Therapy, please contact J. Donald Payne at DPayne@Nanospectra.com.

BACK TO TOP

For Investors and Media:

If you wish to receive further information about AuroLase® Therapy, please contact Info@Nanospectra.com or 713-842-2720.

BACK TO TOP

For Research Collaborators

If you wish to receive further information about Nanospectra's technology, to discuss possible research collaborations, or the purchase of nanoparticles, please contact Products@Nanospectra.com or 713-842-2720.

BACK TO TOP

For Career Opportunities

If you wish to submit a resume to the Company for employment consideration, please send a pdf file to Human_Resources@Nanospectra.com.

BACK TO TOP